1. Executive Summary 2. Research Methodology 3. Introduction 3.1.1 History of Molecular Diagnostics 3.1.2 Molecular Diagnostics vs. Conventional diagnostics 3.1.3 Types of Molecular Diagnostics 4. Molecular Diagnostic Market 4.1 Global Molecular Diagnostics Market Analysis 4.1.1 Market Size by Value (Actual & Forecasted) 4.2.1 Market Share by Segment 4.2.2 Market Share by Discpline 4.2.3 Market Share by Competitors 4.2.4 Market Share by Region 5. Global Molecualr Diagnostics Market Segmentation 5.1 Clinical Infectious Disease Segment 5.1.1 Virology Segment - Human Papilloma virus (HPV) Testing Market 5.1.1.1 Market Size by Value (Actual & Forecasted) 5.1.1.2 Market Size by Volume (Actual & Forecasted) 5.1.1.3 Market Share by Region (Actual & Forecasted) 5.1.1.4 Market Share by Competitors 5.2 Bacteriology - CT/NG Testing Market 5.2.1 Market Size by Value (Actual & Forecasted) 5.2.2 Market Size by Volume (Actual & Forecasted) 5.2.3 Market Share by Region (Actual & Forecasted) 5.2.4 Market Share by Competitors 5.3 Genomics Testing Market – HLA Testing Market 5.3.1 Market Size by Value (Actual & Forecasted) 5.3.2 Human Leukocyte Antigen (HLA) Testing Market 5.4 Blood Donor Screening Segment 6. Global Molecular Diagnostics Market Dynamics 6.1 Market Trends & Developments 6.1.1 Strategic Alliances 6.1.2 Next Generation Sequencing in Clinical Molecular Diagnostics 6.2 Growth Drivers 6.2.1 Surge in Oncology Diagnostics 6.2.2 Prevalence of Reproductive Infectious Disease 6.2.3 Growing geriatric population 6.2.4 Government’s mandate on regular screening of HPV and CT/NG 6.3 Challenges 6.3.1 Complex Regulatory Framework 6.3.2 Lack of Clarity on Reimbursement 7. Competitive Landscape 8. Company Profiles 8.1 Roche Holding AG 8.1.1 Business Overview 8.1.2 Financial Overview 8.1.3 Business Strategies 8.2 Novartis AG 8.2.1 Business Overview 8.2.2 Financial Overview 8.2.3 Business Strategies 8.3 Qiagen NV 8.3.1 Business Overview 8.3.2 Financial Overview 8.3.3 Business Strategies 8.4 Hologic Inc 8.4.1 Business Overview 8.4.2 Financial Overview 8.4.3 Business Strategies

Figure 1: History of Molecular Diagnostics Figure 2: Types of Molecular Diagnostics Figure 3: Understanding Molecular Diagnostics Figure 4: Global Molecular Diagnostics Market Size by Value, 2006-15 (US$ Billions) Figure 5: Global Molecular Diagnostics Market Size by Value Forecasted, 2016E-22E (US$ Billions) Figure 6: Global Molecular Diagnostics Market Share by Application (2016E) Figure 7: Global Molecular Diagnostics Market Share by Discipline (2016E) Figure 8: Global Molecular Diagnostics Market Share by Competitors (2015) Figure 9: Global Molecular Diagnostics Market Share by Region (2015) Figure 10: Global HPV Market Size by Value, 2010-15 (US$ Millions) Figure 11: Global HPV Market Size by Value Forecasted, 2016E-22E (US$ Millions) Figure 12: Global HPV Market Size by Volume, 2010-15 (Million units) Figure 13: Global HPV Market Size by Volume Forecasted, 2016E-20E (Million units) Figure 14: Global HPV Market Share by Region, 2010-15 (%) Figure 15: Global HPV Market Share by Region Forecasted, 2016E-22E (%) Figure 16: Global HPV Market Share by Competitors, 2010-15 (%) Figure 17: Global CT/NG Testing Market Size by Value, 2011-15 (US$ Millions) Figure 18: Global CT/NG Testing Market Size by Value Forecasted, 2016E-22E (US$ Millions) Figure 19: Global CT/NG Testing Market Size by Volume, 2011-15 (Million units) Figure 20: Global CT/NG Testing Market Size by Volume Forecasted, 2016E-22E (Million units) Figure 21: Global CT/NG Testing Market Share by Region, 2011-15 (%) Figure 22: Global CT/NG Testing Market Share by Region Forecasted, 2016E-22E (%) Figure 23: Global CT/NG Market Share by Competitors, 2010-15 (%) Figure 24: Global CT/NG Market Share by Competitors Forecasted, 2016E-22E (%) Figure 25: Global Genetic Testing Market Size by Value, 2007-15 (US$ Billions) Figur 26: Global Genetic Testing Market Size by Value Forecasted, 2016E-22E (US$ Billions) Figure 27: Global Human Leukocyte Antigen (HLA) Testing Market Size by Value, 2011-15 (US$ Million) Figure 28: Global Human Leukocyte Antigen (HLA) Testing Market Size by Value Forecasted, 2016E-22E (US$ Million) Figure 29: Global Molecular Diagnostics Blood Screening Market Size by Value, 2011-15 (US$ Millions) Figure 30: Global Molecular Diagnostics Blood Screening Market Size by Value Forecasted, 2016E-22E (US$ Millions) Table 1: Major M&A in Diagnostics* Table 2: Prominent NGS platforms, the sequencing technology, features and capabilities Figure 31: The US Oncology Market by Segments, 2014-20E (Thousands) Table 3: Cancer Care Cost by Cancer Site, 2010 and 2020E (US$) Figure 32: Incidence of Chlamydia and Gonorrhoea in the US, 2000-2012 (Thousands) Figure 33: Global Ageing Population (65 years and above), 2009-15 (Millions) Table 4: Summary for Recommendations and Evidence of US Screening Guidelines Table 5: Global Molecular Daignostics Market Players Capability Analysis Figure 34: Molecular Diagnostic Revenue by Company, 2015 (US$ Billions) Figure 35: Global Molecular Diagnostic Players Growth Rate (2015) Figure 36: Molecular Diagnostic System Installed Base in US Hospitals as % of Total Instruments (March’2015) Figure 37: Roche Holding Revenue by Business Segment (FY2015) Figure 38: Roche Holding Revenue, FY2010-FY15 (US$ Billions) Figure 39: Novartis AG Revenue by Business Segment (FY2015) Figure 40: Novartis AG Revenue, FY2011-FY2015 (US$ Billions) Figure 41: Qiagen NV Revenue by Business Segment (FY2015) Figure 42: Qiagen NV Revenue by Customer Classes (FY2015) Figure 43: Qiagen NV Revenue, FY2011-FY2015 (US$ Billions) Figure 44: Hologic Inc Revenue by Business Segments (2015) Figure 45: Hologic Inc Revenue, FY2011-FY2015 (US$ Billions)

Roche Holdings, Novartis AG, Hologic Inc, Qiagen NV